Study supports PSA velocity risk count.
Mike
M
Fillon
D000367:Age Factors; D014408:Biomarkers, Tumor / Q000097:blood*; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000276:immunology; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology* / Q000517:prevention & control; D018570:Risk Assessment; D012307:Risk Factors; D019564:Unnecessary Procedures; D057832:Watchful Waiting
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen